Company Rheuma Medical Research Srl with Fiscal Code 33550604
recorded a turnover of 2024 of
39.780,
with a net profit of
21.469
and having an average number of employees of
1.
The company operates in the field of Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Rheuma Medical Research Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
43.524
40.305
47.769
45.362
56.264
40.868
41.169
46.633
37.900
39.780
Total Income - EUR
43.774
41.264
48.506
45.536
56.982
41.205
41.670
47.623
37.929
39.824
Total Expenses - EUR
16.966
11.233
11.112
13.281
11.626
10.569
11.741
11.494
16.414
17.342
Gross Profit/Loss - EUR
26.808
30.031
37.394
32.255
45.355
30.636
29.930
36.130
21.515
22.483
Net Profit/Loss - EUR
25.499
28.800
35.945
30.894
43.655
29.489
28.840
35.031
21.143
21.469
Employees
0
0
0
0
0
0
0
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 5.6%, from 37.900 euro in the year 2023, to 39.780 euro in 2024.
The Net Profit increased by 443 euro, from 21.143 euro in 2023, to 21.469 in the last year.
Check the financial reports for the company - Rheuma Medical Research Srl
Financial Rating - RHEUMA MEDICAL RESEARCH SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Rheuma Medical Research Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Rheuma Medical Research Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Rheuma Medical Research Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Rheuma Medical Research Srl - CUI 33550604
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
738
2.668
2.627
612
2.616
1.334
184
0
0
1.959
Current Assets
35.618
27.974
35.414
31.903
44.490
31.478
60.840
35.728
22.592
42.233
Inventories
0
0
0
0
0
0
0
0
0
0
Receivables
5.034
2.450
1.185
5.312
5.423
1.371
6.060
24.730
5.622
3.453
Cash
30.584
25.525
34.228
26.591
39.066
30.106
54.780
10.999
16.970
38.780
Shareholders Funds
33.110
29.789
36.233
31.295
44.926
31.538
59.678
35.233
21.192
42.542
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
3.245
854
1.808
1.220
2.179
1.347
1.345
590
1.400
1.649
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"7219 - 7219"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
42.233 euro in 2024 which includes Inventories of
0 euro, Receivables of
3.453 euro and cash availability of
38.780 euro.
The company's Equity was valued at
42.542 euro, while total Liabilities amounted to
1.649 euro.
Equity increased by 21.469 euro, from 21.192 euro in 2023, to 42.542 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Rheuma Medical Research Srl